Alyeska Investment Group’s BrightSpring Health Services BTSG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-200,000
Closed -$7.49M 763
2025
Q4
$7.49M Sell
200,000
-1,784,365
-90% -$59.8M 0.02% 425
2025
Q3
$58.7M Buy
1,984,365
+316,965
+19% +$7.37M 0.18% 151
2025
Q2
$39.3M Buy
+1,667,400
New +$34.8M 0.14% 189
2024
Q4
Sell
-357,633
Closed -$5.25M 678
2024
Q3
$5.25M Buy
357,633
+50,000
+16% +$627K 0.03% 348
2024
Q2
$3.49M Sell
307,633
-900,000
-75% -$9.83M 0.02% 369
2024
Q1
$13.1M Buy
+1,207,633
New +$12.1M 0.08% 246

Other funds holding BTSG

Alyeska Investment Group's BTSG Position: Q1 2026 in Review

Alyeska Investment Group sold out of BrightSpring Health Services (BTSG) in Q1 2026, closing a stake of 200,000 shares — an estimated $7.49M sold.

Alyeska Investment Group first reported a position in BTSG in Q1 2024 and held it in 6 quarters. The position peaked at $58.7M in Q3 2025. 335 funds tracked by Wall St. Rank hold BTSG as of Q1 2026.

  • Alyeska Investment Group reported no remaining BrightSpring Health Services position as of Q1 2026 after selling out during the quarter.
  • Alyeska Investment Group sold 200,000 BrightSpring Health Services shares in Q1 2026, an estimated $7.49M.
  • Alyeska Investment Group first reported a position in BrightSpring Health Services in Q1 2024 and held it in 6 quarters.
  • Alyeska Investment Group's BrightSpring Health Services position peaked at $58.7M in Q3 2025.
  • 335 funds tracked by Wall St. Rank held BrightSpring Health Services as of Q1 2026.

Based on Alyeska Investment Group's 13F filing for Q1 2026, filed 15 May 2026.